Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Science / Health/  Oxford covid vaccine seen effective in elderly people: Report
BackBack

Oxford covid vaccine seen effective in elderly people: Report

The Oxford covid vaccine is considered a frontrunner in the race to Covid-19 vaccine
  • The outcome of the trials is being closely watched around the world
  • The Oxford covid vaccine is considered a frontrunner in the race to protect the global population from Covid-19Premium
    The Oxford covid vaccine is considered a frontrunner in the race to protect the global population from Covid-19

    AstraZeneca’s vaccine has produced a robust immune response in elderly people, the Financial Times reported, citing two unidentified people familiar with the finding. The vaccine, which AstraZeneca is producing in collaboration with the University of Oxford, produced protective antibodies and T-cells in older age groups, the FT reported.

    The elderly people are seen at highest risk from the coronavirus.

    Findings on immunogenicity blood tests carried on a subset of older participants echo data released in July that showed the vaccine generated “robust immune responses" in healthy adults aged 18-55 years, the report said. Oxford declined to comment to the FT.

    The Oxford covid vaccine is considered a frontrunner in the race to Covid-19 vaccine and the outcome of the trials is being closely watched around the world.

    Meanwhile, AstraZeneca Plc has resumed the US trial of its experimental COVID-19 vaccine after approval by regulators. AstraZeneca had paused its US trial in September after a report of an illness in a participant in the company's UK trial.

    The British-Swedish drugmaker has signed several supply and manufacturing deals with companies and governments around the world as it gets closer to reporting early results of a late-stage clinical trial

    The Oxford covid vaccine is undergoing trials in India. Pune-based Serum Institute is making potential vaccines from AstraZeneca, Novavax and Codagenix Inc, as well as developing its own.

    Called AZD1222 or ChAdOx1 nCoV-19, the Oxford covid vaccine is a recombinant viral vector vaccine. It uses a weakened version of a chimpanzee common cold virus that encodes instructions for making proteins from the novel coronavirus to generate an immune response and prevent infection. (With Agency Inputs)

    Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

    Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
    More Less
    Published: 26 Oct 2020, 10:12 AM IST
    Next Story footLogo
    Recommended For You
    Switch to the Mint app for fast and personalized news - Get App